mTOR inhibitor therapy for patients with carcinoid

Guido Rindi; M. Caplin

doi:10.1016/S0140-6736(11)61789-3

mTOR inhibitor therapy for patients with carcinoid

Guido Rindi
, M. Caplin

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

No abstract

Lingua originale	Inglese
pagine (da-a)	1978-1980
Numero di pagine	3
Rivista	LANCET
Volume	378
DOI	https://doi.org/10.1016/S0140-6736(11)61789-3
Stato di pubblicazione	Pubblicato - 2011

Keywords

Antineoplastic Agents, Hormonal
Carcinoid Tumor
Female
Humans
Immunosuppressive Agents
Male
Malignant Carcinoid Syndrome
Octreotide
Sirolimus

Accesso al documento

10.1016/S0140-6736(11)61789-3

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{122dc77fca524f06ab5a57b3b2bc3d0e,

title = "mTOR inhibitor therapy for patients with carcinoid",

abstract = "No abstract",

keywords = "Antineoplastic Agents, Hormonal, Carcinoid Tumor, Female, Humans, Immunosuppressive Agents, Male, Malignant Carcinoid Syndrome, Octreotide, Sirolimus, Antineoplastic Agents, Hormonal, Carcinoid Tumor, Female, Humans, Immunosuppressive Agents, Male, Malignant Carcinoid Syndrome, Octreotide, Sirolimus",

author = "Guido Rindi and M. Caplin",

year = "2011",

doi = "10.1016/S0140-6736(11)61789-3",

language = "English",

volume = "378",

pages = "1978--1980",

journal = "LANCET",

issn = "0923-7577",

publisher = "Editions Scientifique \& Medical Elsevier:23 Rue Linois, F 75724 Paris Cedex 15 France:011 33 1 71724646, INTERNET: http://www.elsevier.fr, Fax: 011 33 1 71724664",

}

TY - JOUR

T1 - mTOR inhibitor therapy for patients with carcinoid

AU - Rindi, Guido

AU - Caplin, M.

PY - 2011

Y1 - 2011

N2 - No abstract

AB - No abstract

KW - Antineoplastic Agents, Hormonal

KW - Carcinoid Tumor

KW - Female

KW - Humans

KW - Immunosuppressive Agents

KW - Male

KW - Malignant Carcinoid Syndrome

KW - Octreotide

KW - Sirolimus

KW - Antineoplastic Agents, Hormonal

KW - Carcinoid Tumor

KW - Female

KW - Humans

KW - Immunosuppressive Agents

KW - Male

KW - Malignant Carcinoid Syndrome

KW - Octreotide

KW - Sirolimus

UR - http://hdl.handle.net/10807/41806

U2 - 10.1016/S0140-6736(11)61789-3

DO - 10.1016/S0140-6736(11)61789-3

M3 - Article

SN - 0923-7577

VL - 378

SP - 1978

EP - 1980

JO - LANCET

JF - LANCET

ER -

mTOR inhibitor therapy for patients with carcinoid

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo